Phase 4WithdrawnINTERVENTIONAL
Liraglutide Actions on the Liver: Effects on Glucose Phosphorylation
ClinicalTrials.gov · NCT02198209 · Registry updated: 2019-09-30
- Condition / research focus
- Type 2 Diabetes
- Sponsor
- Cedars-Sinai Medical Center
- Countries with listed sites
- United States
- Registry dates and results
- Start: 2019-12. Completion: 2020-12 (may be estimated). No results posted in this registry response.
Products and interventions (1)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
- Liraglutide (drug) — also listed as: Victoza
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
- Cedars Sinai Medical Center
Los Angeles, California, United States
Site recruitment: Not reported